Send to a Friend Font Size: Increase Decrease

GUD and KYKOY Related Headlines

Sep 29, 2026 08:00AM Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America

GUD and KYKOY Related Press Releases

Sep 29, 2026 08:00AM Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America

GUD and KYKOY Related SEC Filings